Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth I Ataga

Showing results (21-30 of 133) with videos related to

Pageof 14
Sort By:
The New England Journal of Medicine|May 4, 2017
Crizanlizumab in Sickle Cell DiseaseKenneth I Ataga, Abdullah Kutlar, Julie Kanter
Hematology/Oncology Clinics of North America|November 18, 2022
The Evolving Landscape of Drug Therapies for Sickle Cell DiseaseParul Rai, Payal C Desai, Kenneth I Ataga
Blood Reviews|January 19, 2016
Coagulation abnormalities of sickle cell disease: Relationship with clinical outcomes and the effect of disease modifying therapiesDenis Noubouossie, Nigel S Key, Kenneth I Ataga
JAMA Internal Medicine|July 22, 2024
Concerns With Statistical Analysis of 2016 CDC Opioid Guideline and Sickle Cell Outcomes-ReplyHyeun Ah Kang, Yahan Zhang, Kenneth I Ataga
Nature Reviews. Nephrology|February 22, 2022
The nephropathy of sickle cell trait and sickle cell diseaseKenneth I Ataga, Santosh L Saraf, Vimal K Derebail
Pain Management Nursing : Official Journal of the American Society of Pain Management Nurses|January 25, 2013
Care seeking for pain in young adults with sickle cell diseaseCoretta M Jenerette, Cheryl A Brewer, Kenneth I Ataga
JACC. Cardiovascular Imaging|February 22, 2016
Sickle Cardiomyopathy: The Missing Forest in the TreesMelissa C Caughey, Kenneth I Ataga, Alan L Hinderliter
British Journal of Haematology|September 15, 2007
Beta-thalassaemia and sickle cell anaemia as paradigms of hypercoagulabilityKenneth I Ataga, Maria D Cappellini, Eliezer A Rachmilewitz
Current Opinion in Hematology|July 3, 2013
Hemostatic abnormalities in sickle cell diseaseMing Y Lim, Kenneth I Ataga, Nigel S Key
American Journal of Hematology|May 21, 2014
The glomerulopathy of sickle cell diseaseKenneth I Ataga, Vimal K Derebail, David R Archer
Pageof 14

Showing results (21-30 of 133) with videos related to

Sort By:
Pageof 14
The New England Journal of Medicine|May 4, 2017
Crizanlizumab in Sickle Cell DiseaseKenneth I Ataga, Abdullah Kutlar, Julie Kanter
Hematology/Oncology Clinics of North America|November 18, 2022
The Evolving Landscape of Drug Therapies for Sickle Cell DiseaseParul Rai, Payal C Desai, Kenneth I Ataga
Blood Reviews|January 19, 2016
Coagulation abnormalities of sickle cell disease: Relationship with clinical outcomes and the effect of disease modifying therapiesDenis Noubouossie, Nigel S Key, Kenneth I Ataga
JAMA Internal Medicine|July 22, 2024
Concerns With Statistical Analysis of 2016 CDC Opioid Guideline and Sickle Cell Outcomes-ReplyHyeun Ah Kang, Yahan Zhang, Kenneth I Ataga
Nature Reviews. Nephrology|February 22, 2022
The nephropathy of sickle cell trait and sickle cell diseaseKenneth I Ataga, Santosh L Saraf, Vimal K Derebail
Pain Management Nursing : Official Journal of the American Society of Pain Management Nurses|January 25, 2013
Care seeking for pain in young adults with sickle cell diseaseCoretta M Jenerette, Cheryl A Brewer, Kenneth I Ataga
JACC. Cardiovascular Imaging|February 22, 2016
Sickle Cardiomyopathy: The Missing Forest in the TreesMelissa C Caughey, Kenneth I Ataga, Alan L Hinderliter
British Journal of Haematology|September 15, 2007
Beta-thalassaemia and sickle cell anaemia as paradigms of hypercoagulabilityKenneth I Ataga, Maria D Cappellini, Eliezer A Rachmilewitz
Current Opinion in Hematology|July 3, 2013
Hemostatic abnormalities in sickle cell diseaseMing Y Lim, Kenneth I Ataga, Nigel S Key
American Journal of Hematology|May 21, 2014
The glomerulopathy of sickle cell diseaseKenneth I Ataga, Vimal K Derebail, David R Archer
Pageof 14